Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

PharmExec
pharmexec.com > view > boards-ai-500-years-experience-life-sciences-takeaways-board-forum

Boards, AI, and 500 Years of Experience in Life Sciences: Takeaways from the 2026 Life Sciences Board Forum

3+ hour, 15+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

Hoodline
hoodline.com > 2026 > 09 > palo-alto-s-frazier-life-sciences-piles-1-1b-into-public-biotech-fund

Frazier Life Sciences Raises $1.1B for Public Fund

8+ hour, 36+ min ago   (202+ words) Frazier Life Sciences has closed more than $1.1 billion in new capital commitments to its Public Fund, pushing the long-only investment vehicle's total committed capital to roughly $2.8 billion. The Palo Alto-based firm announced the raise Thursday, marking one of the largest…...

BIOENGINEER.ORG
bioengineer.org > enzyme-trick-turns-bioethanol-waste-oil-into-high-value-renewable-fuel-additives

Enzyme Trick Turns Bioethanol Waste Oil Into High-Value Renewable Fuel

5+ hour, 57+ min ago   (73+ words) A humble byproduct of bioethanol fermentation, long relegated to low-value disposal, could soon find itself blended into the world’s fuel tanks. Researchers at Lund University in Sweden have shown that fusel oil, the mixture of higher alcohols that distillers skim…...

@insidermonkey
insidermonkey.com > blog > press-releases > life-sciences-companies-present-live-at-the-september-17-virtual-investor-forum-1836700

Life Sciences Companies Present Live at the September 17 Virtual Investor Forum

21+ hour, 47+ min ago   (322+ words) NEW YORK, NY – B2i Digital, Inc. invites investors to the Life Sciences Virtual Investor Forum, a B2i Digital Featured Conference, taking place online on Thursday, September 17, 2026, and hosted by Virtual Investor Conferences. B2i Digital is the Official Marketing Partner, putting the combined reach…...

ynetglobal
ynetnews.com > magazine > article > h1tnivboml

After building a fintech giant, Alon Gonen turned his own body into an experiment

17+ hour, 15+ min ago   (1563+ words) Plus500 co-founder Alon Gonen eats two meals a day, grows his own plantains, gave up his office chair and even invested in a farm to control where his meat comes from, after a health scare pushed him to overhaul his lifestyle…...

Barbados Today
barbadostoday.bb > 09/11/2026 > microbe-patents-could-unlock-billions-export-barbados

Microbe patents???could unlock billions??? - Export Barbados

1+ day, 7+ hour ago   (614+ words) The government’s move to patent a group of microbes discovered by UWI Cave Hill science researcher Dr Bidyut Mohapatra could create multi-billion-dollar opportunities for Barbados, the country’s export promotion chief has said. The push to patent began after Dr Mohapatra…...

Bisnow
bisnow.com > events > national > life-sciences > international-life-sciences-biotech-conference-9773

International Life Sciences & Biotech Conference

1+ week, 5+ day ago   (1586+ words) We take all submissions seriously. We'll reach out if we have an opportunity now or in the future. Managing Director, Life Science San Diego Market Lead Scott Brinker has served as our President and Chief Executive Officer and a member…...

Yahoo Finance
finance.yahoo.com > m > 7422adb6-7da7-3f11-acea-dd074da4a312 > novartis%3A-more-pain-on-the.html

Novartis: More Pain on the Way?

1+ day, 7+ hour ago   (100+ words) Can it get any worse for Novartis’ U.S. stock? The Swiss company said Tuesday that del-desiran, part of a recent acquisition, reached the end of the line in a trial for a rare neuromuscular disease. The drugmaker’s U.S.-listed…...